tiprankstipranks
XBiotech (XBIT)
NASDAQ:XBIT
Holding XBIT?
Track your performance easily

XBiotech (XBIT) Income Statement

327 Followers

XBiotech Income Statement

Last quarter (Q ), XBiotech's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q, XBiotech's net income was $-4.63M. See XBiotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
--$ 4.01M$ 18.39M$ 44.00M$ 0.00
Cost of Revenue
--$ 651.00K$ -5.82M$ 34.55M$ 0.00
Gross Profit
--$ 3.36M$ 12.57M$ 9.45M$ 0.00
Operating Expense
$ 23.22M$ 37.51M$ 37.85M$ -37.66M$ 27.73M$ 31.23M
Operating Income
$ -23.22M$ -37.51M$ -34.49M$ -43.48M$ -18.28M$ -31.23M
Net Non Operating Interest Income Expense
$ 5.29M--$ 467.00K$ 2.46M$ 564.00K
Other Income Expense
$ -6.02M$ -11.30M$ -3.70M$ -18.26M$ 2.99M$ 749.12M
Pretax Income
$ -24.31M$ -24.31M$ -33.59M$ -25.46M$ -12.83M$ 718.45M
Tax Provision
$ 317.00K$ 244.00K$ -688.00K$ -8.04M$ -1.61M$ 49.82M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -10.34M$ -24.56M$ -32.90M$ -17.41M$ -11.22M$ 668.63M
Basic EPS
$ -0.81$ -0.81$ -1.08$ -0.58$ -0.36$ 17.17
Diluted EPS
$ -0.81$ -0.81$ -1.08$ -0.58$ -0.36$ 14.44
Basic Average Shares
$ 121.75M$ 30.44M$ 30.44M$ 30.04M$ 30.82M$ 38.95M
Diluted Average Shares
$ 121.75M$ 30.44M$ 30.44M$ 30.04M$ 30.82M$ 46.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 23.22M$ 37.51M$ 38.50M$ -43.48M$ 62.27M$ 31.23M
Net Income From Continuing And Discontinued Operation
$ -24.56M$ -24.56M$ -32.90M$ -17.41M$ -11.22M$ 668.63M
Normalized Income
$ -17.26M$ -19.21M$ -34.28M-$ -14.28M$ 669.46M
Interest Expense
------
EBIT
$ -30.95M$ -37.51M$ -33.59M$ -25.93M$ -18.28M$ -31.23M
EBITDA
$ -22.58M$ -35.77M$ -30.97M$ -23.28M$ -16.04M$ -28.87M
Currency in USD

XBiotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis